[Federal Register Volume 78, Number 99 (Wednesday, May 22, 2013)]
[Notices]
[Pages 30331-30332]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-12114]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application;
Alltech Associates, Inc.
Pursuant to Sec. 1301.33(a), Title 21 of the Code of Federal
Regulations (CFR), this is notice that on March 28, 2013, Alltech
Associates Inc., 2051 Waukegan Road, Deerfield, Illinois 60015, made
application by renewal to the Drug Enforcement Administration (DEA) to
be registered as a bulk manufacturer of the following basic classes of
controlled substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Methcathinone (1237)........................ I
N-Ethylamphetamine (1475)................... I
N,N-Dimethylamphetamine (1480).............. I
4-Methylaminorex (cis isomer) (1590)........ I
Alpha-ethyltryptamine (7249)................ I
Lysergic acid diethylamide (7315)........... I
2C-T-7 (2,5-Dimethoxy-4-(n)- I
Propylthiophenethylamine) (7348).
Tetrahydrocannabinols (7370)................ I
Mescaline (7381)............................ I
2C-T-2 (2-(4-Ethylthio-2,5- I
dimethoxyphenyl)ethanamine)(7385).
4-Bromo-2,5-dimethoxyamphetamine (7391)..... I
4-Bromo-2,5-dimethoxyphenethylamine (7392).. I
4-Methyl-2,5-dimethoxyamphetamine (7395).... I
2,5-Dimethoxyamphetamine (7396)............. I
2,5-Dimethoxy-4-ethylamphetamine (7399)..... I
3,4-Methylenedioxyamphetamine (7400)........ I
N-Hydroxy-3,4-methylenedioxyamphetamine I
(7402).
3,4-Methylenedioxy-N-ethylamphetamine (7404) I
3,4-Methylenedioxymethamphetamine (7405).... I
4-Methoxyamphetamine (7411)................. I
5-Methoxy-N-N-dimethyltryptamine (7431)..... I
Alpha-methyltryptamine (7432)............... I
Bufotenine (7433)........................... I
Diethyltryptamine (7434).................... I
Dimethyltryptamine (7435)................... I
Psilocybin (7437)........................... I
Psilocyn (7438)............................. I
5-Methoxy-N,N-diisopropyltryptamine (7439).. I
N-Ethyl-1-phenylcyclohexylamine (7455)...... I
1-(1-Phenylcyclohexyl)pyrrolidine (7458).... I
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) I
[[Page 30332]]
2C-E (2-(2,5-Dimethoxy-4- I
ethylphenyl)ethanamine) (7509).
2C-H (2-(2,5-Dimethoxyphenyl)ethanamine) I
(7517).
2C-1(2-(4-lodo-2,5- I
dimethoxyphenyl)ethanamine) (7518).
2C-C (2-(4-Chloro-2,5- I
dimethoxyphenyl)ethanamine (7519).
2C-T-4 (2-(4-isopropylthio)-2,5- I
dimethoxyphenyl) ethanamine) (7532).
Dihydromorphine (9145)...................... I
Heroin (9200)............................... I
Normorphine (9313).......................... I
Methamphetamine (1105)...................... II
1-Phenylcyclohexylamine (7460).............. II
Phencyclidine (7471)........................ II
Phenylacetone (8501)........................ II
1-Piperidinocyclohexanecarbonitrile (8603).. II
Cocaine (9041).............................. II
Codeine (9050).............................. II
Dihydrocodeine (9120)....................... II
Ecgonine (9180)............................. II
Meperidine intermediate-B (9233)............ II
Noroxymorphone (9668)....................... II
------------------------------------------------------------------------
The company plans to manufacture high purity drug standards used
for analytical applications only in clinical, toxicological, and
forensic laboratories.
Any other such applicant, and any person who is presently
registered with DEA to manufacture such substances, may file comments
or objections to the issuance of the proposed registration pursuant to
21 CFR Sec. 1301.33(a).
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than July 22, 2013.
Dated: May 14, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2013-12114 Filed 5-21-13; 8:45 am]
BILLING CODE 4410-09-P